Please assess the completion status of the following clinical trial:

Trial Title: Use of Phenoxybenzamine [PBZ] IV to Assist High Flow Low Pressure Perfusion [HFLPP] on Cardio-pulmonary Bypass

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~Patients~The following patients are candidates for receiving PBZ for HFLPP. These include:~1. All patients under 16 kg.~2. Those patients between 16-18 kg whose pre bypass hemoglobin is \<16 g/dl~3. All patients are less than 18 years of age~Exclusion Criteria:~1. Those with bloodless prime in Cardiopulmonary bypass circuit~2. Age \> 18years~3. Wt. \>16 kg

- Gender: ALL
- Minimum Age: None
- Maximum Age: 18 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Treatment Group

Based on this trial design, predict the completion outcome and termination type (if applicable).